These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31465834)

  • 41. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binary to ternary drug-drug molecular adducts of the antihypertensive drug ketanserin (KTS) with advanced physicochemical properties.
    Rout SR; Kenguva G; Giri L; Kar A; Dandela R
    Chem Commun (Camb); 2023 Apr; 59(31):4640-4643. PubMed ID: 36988099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computational and Experimental Screening Approaches to Aripiprazole Salt Crystallization.
    Shah HS; Michelle C; Xie T; Chaturvedi K; Kuang S; Abramov YA
    Pharm Res; 2023 Dec; 40(12):2779-2789. PubMed ID: 37127778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
    Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.
    Paus R; Ji Y; Vahle L; Sadowski G
    Mol Pharm; 2015 Aug; 12(8):2823-33. PubMed ID: 26107071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting the Solubility of Pharmaceutical Cocrystals in Solvent/Anti-Solvent Mixtures.
    Lange L; Heisel S; Sadowski G
    Molecules; 2016 May; 21(5):. PubMed ID: 27164075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved pharmacokinetics of AMG 517 through co-crystallization. Part 1: comparison of two acids with corresponding amide co-crystals.
    Stanton MK; Kelly RC; Colletti A; Kiang YH; Langley M; Munson EJ; Peterson ML; Roberts J; Wells M
    J Pharm Sci; 2010 Sep; 99(9):3769-78. PubMed ID: 20665842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling solid-state transformations occurring in dissolution testing.
    Laaksonen T; Aaltonen J
    Int J Pharm; 2013 Apr; 447(1-2):218-23. PubMed ID: 23506958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computational Screening of Drug Solvates.
    Loschen C; Klamt A
    Pharm Res; 2016 Nov; 33(11):2794-804. PubMed ID: 27469323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lamotrigine: Design and synthesis of new multicomponent solid forms.
    Évora AOL; Castro RAE; Maria TMR; Ramos Silva M; Canotilho J; Eusébio MES
    Eur J Pharm Sci; 2019 Mar; 129():148-162. PubMed ID: 30639400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Directed evolution of an amine transaminase for the synthesis of an Apremilast intermediate via kinetic resolution.
    Xiang C; Wu S; Bornscheuer UT
    Bioorg Med Chem; 2021 Aug; 43():116271. PubMed ID: 34171757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder.
    Lee HL; Vasoya JM; Cirqueira ML; Yeh KL; Lee T; Serajuddin AT
    Mol Pharm; 2017 Apr; 14(4):1278-1291. PubMed ID: 28245127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystallization of probucol from solution and the glassy state.
    Kawakami K; Ohba C
    Int J Pharm; 2017 Jan; 517(1-2):322-328. PubMed ID: 27979761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dielectric study of equimolar acetaminophen-aspirin, acetaminophen-quinidine, and benzoic acid-progesterone molecular alloys in the glass and ultraviscous states and their relevance to solubility and stability.
    Johari GP; Kim S; Shanker RM
    J Pharm Sci; 2010 Mar; 99(3):1358-74. PubMed ID: 19780138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
    Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
    Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A
    Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
    Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.